SCHEMBL6265152

SCHEMBL6265152

COc1ccc(CN(Cc2ccc(OC)cc2)c2cc(Cl)nc(N)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.55
KDM4E B2RXH2 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.53
MAPT P10636 2/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
HSP90AB1 P08238 3/20 0.47
HSP90AA1 P07900 2/20 0.47
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 4/20 0.46
CYP2D6 P10635 2/20 0.46
ATM Q13315 1/20 0.46
RAB9A P51151 1/20 0.45
CHRNA7 P36544 2/20 0.42
PIK3CD O00329 1/20 0.41
LMNA P02545 2/20 0.41
NOS1 P29475 1/20 0.41
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28736302 0.88 SMN1; SMN2 (0.71) KMT2AKDM4ESMN1; SMN2MAPTPOLB
SCHEMBL29610081 0.88 SMN1; SMN2 (0.71) KMT2AKDM4ESMN1; SMN2MAPTPOLB
SCHEMBL114531 0.84 PIK3CA (0.49) KMT2AKDM4ESMN1; SMN2MAPTNPSR1
SCHEMBL24460959 0.84 LMNA (0.43) KMT2AKDM4ESMN1; SMN2MAPTPOLB
SCHEMBL24272825 0.82 TSPO (0.44) KMT2AKDM4ESMN1; SMN2MAPTHSP90AA1
SCHEMBL6265329 0.81 SMN1; SMN2 (0.73) KMT2AKDM4ESMN1; SMN2HSP90AB1HSP90AA1
SCHEMBL30759080 0.81 PIK3CD (0.41) KMT2ASMN1; SMN2MAPTGAAHSP90AA1
SCHEMBL14806844 0.79 PIK3CA (0.45) KMT2AKDM4ESMN1; SMN2MAPTHSP90AA1
SCHEMBL28865948 0.78 LMNA (0.43) KMT2AMAPTHSP90AA1ALDH1A1CYP2D6
SCHEMBL21379903 0.78 PIK3CA (0.48) KMT2ASMN1; SMN2MAPTPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066266-B1 CYCLIN DEPENDENT KINASE INHIBITORS CANCER REC TECH LTD (GB) 2005-11-09 EP disclosed
US-6677345-B1 PYRMIDINE DERIVATIVE ANTITUMOR AND ANTIPROLIFERATIVE AGENTS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 2004-01-13 US disclosed